Search results
RedHill Says Opaganib Has Potential As Nuclear Radiation Protection For Homeland Security...
Benzinga via Yahoo Finance· 1 year agoRedHill Biopharma Ltd (NASDAQ: RDHL) said that preclinical data, recently published in the...
RedHill Biopharma (RDHL) Up on New Patent for COVID-19 Candidate
Zacks via Yahoo Finance· 2 years agoRedHill Biopharma (RDHL) receives a new patent from the United States Patent and Trademark Office...
RedHill Biopharma Shares Surge New Treatment Patent For Its Late-Stage COVID-19 Candidate
Benzinga via Yahoo Finance· 2 years agoThe United States Patent and Trademark Office (USPTO) granted a further method of use patent for...
RedHill Biopharma Says Its Oral Broad-Acting Antivirals Inhibit Dominant Omicron Sub-Variant BA.5
Benzinga via Yahoo Finance· 2 years agoRedHill Biopharma Ltd (NASDAQ: RDHL) announced study results showing in vitro efficacy against the...
RedHill (RDHL) Up on Orphan Drug Tag for NTM Disease Drug
Zacks via Yahoo Finance· 2 years agoRedHill Biopharma RDHL announced that the European Commission (EC) has granted orphan-drug...
Cathie Wood’s Latest Portfolio: 10 New Stock Picks in 2022
Insider Monkey via Yahoo Finance· 2 years agoIn this article we will discuss some new stock picks of Cathie Wood’s hedge fund. You can skip this...
Gilead’s Quiet Revolution: Is GILD the Next Big Stock to Soar?
InvestorPlace via Yahoo Finance· 4 months agoBiotechnology company Gilead Sciences (NASDAQ:GILD) wasn’t a “Magnificent Seven” company or a darling of the financial markets in 2023. Yet, GILD stock deserves a long-overdue rally in 2024.